BIRDX | CGREX | BIRDX / CGREX | |
Total Expense Ratio | 0.20 | 2.17 | 9% |
Annual Report Gross Expense Ratio | 0.20 | 2.17 | 9% |
Fund Existence | 10 years | 20 years | - |
Gain YTD | 7.661 | 5.649 | 136% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 1000 | 200,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 240M | 135M | 178% |
Annual Yield % from dividends | 2.69 | 1.29 | 208% |
Returns for 1 year | -4.92 | 8.14 | -60% |
Returns for 3 years | -4.81 | -7.12 | 68% |
Returns for 5 years | 9.31 | -3.03 | -307% |
Returns for 10 years | N/A | -12.27 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTCHX | 66.08 | 0.94 | +1.44% |
Invesco Technology Investor | |||
VNVAX | 24.31 | 0.20 | +0.83% |
Natixis Vaughan Nelson Mid Cap A | |||
AXVIX | 18.20 | 0.10 | +0.55% |
Acclivity Small Cap Value I | |||
FBDIX | 117.80 | 0.59 | +0.50% |
Franklin Biotechnology Discovery A | |||
HSWCX | 20.31 | 0.03 | +0.15% |
Hartford Schroders International Stk C |